focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.00
Bid: 115.00
Ask: 117.00
Change: 1.00 (0.87%)
Spread: 2.00 (1.739%)
Open: 116.00
High: 118.00
Low: 115.00
Prev. Close: 115.00
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

7 Feb 2024 07:00

RNS Number : 2370C
Litigation Capital Management Ltd
07 February 2024
 

7 February 2024

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Notice of Results

 

Litigation Capital Management Limited (AIM:LIT), an alternative asset manager specialising in dispute financing solutions internationally, will announce its results for the half year ended 31 December 2023 on Tuesday 19 March 2024.

 

A webinar presentation for analysts will take place at 9.30am on the day. Analysts wishing to attend should contact lcm@tavistock.co.uk to register.

 

As part of its commitment to engaging equally with all investors, LCM will also be hosting a webinar for investors at 11.00 a.m. on Tuesday 19 March. If you would like to attend this presentation, please register using the following link:

 

https://www.investormeetcompany.com/litigation-capital-management-limited/register-investor

 

The presentation is open to all existing and potential shareholders. Investors who already follow LCM on the Investor Meet Company platform will automatically be invited.

 

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the event.

 

 

Enquiries

 

Litigation Capital Management

c/o Tavistock PR 

Patrick Moloney, Chief Executive Officer

 

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

Tavistock PR

Tel: 020 7920 3150

Tim Pearson

lcm@tavistock.co.uk

Katie Hopkins

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management.

 

Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORMZGGZNVMGDZM
Date   Source Headline
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20234:51 pmRNSDirector/PDMR Shareholding
31st Oct 20233:53 pmRNSExercise of Awards
17th Oct 20231:00 pmRNSResult of AGM
10th Oct 20237:00 amRNSTransaction in Own Shares
9th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20231:40 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSShare Buyback Programme
2nd Oct 20237:00 amRNSDividend currency entitlement
19th Sep 20237:00 amRNSFinal Results
13th Sep 20231:00 pmRNSLondon Investor Event
12th Sep 20234:17 pmRNSNotice of AGM - Correction
12th Sep 20237:00 amRNSNotice of AGM
4th Sep 20237:00 amRNSSettlement in Australian class action
30th Aug 20237:00 amRNSNotice of Results
27th Jul 20237:00 amRNSUpdate following Supreme Court ruling
20th Jul 20237:00 amRNSProgress on Fund I investment
18th Jul 20237:00 amRNSFair Value Accounting and Dividend Payment
22nd Jun 20237:00 amRNSSuccessful resolution of balance sheet investment
19th Jun 20237:00 amRNSResolution of Investment
15th May 20239:48 amRNSSettlement in Australian class action
3rd Apr 20237:00 amRNSResolution of investment
20th Mar 20237:00 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSHalf-year Report
9th Mar 20237:00 amRNSSettlement in Australian class action
27th Feb 20239:30 amRNSNotice of Results
23rd Feb 20237:00 amRNSProgress on direct balance sheet investment
20th Feb 20237:00 amRNSSuccessful settlement in the Carillion claim
20th Dec 20227:00 amRNSProgress on portfolio of Investments
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20227:04 amRNSResult of AGM
20th Oct 20227:00 amRNSNew Litigation Finance Agreement
19th Oct 20229:26 amRNSNotice of AGM
13th Oct 20223:44 pmRNSIncentive Awards
4th Oct 20227:00 amRNSSecond close of Global Alternative Returns Fund II
29th Sep 20229:30 amRNSDirector/PDMR Shareholding
26th Sep 20226:00 pmRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNSFinal Results
23rd Aug 20227:00 amRNSNotice of Results
15th Jul 20228:22 amRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSMarket Update
16th May 20227:00 amRNSLitigation Finance Agreement
4th May 202210:15 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.